David J. Lloyd

6.5k total citations · 2 hit papers
96 papers, 4.7k citations indexed

About

David J. Lloyd is a scholar working on Molecular Biology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David J. Lloyd has authored 96 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Surgery and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David J. Lloyd's work include Pancreatic function and diabetes (13 papers), Microstructure and mechanical properties (9 papers) and Metabolism, Diabetes, and Cancer (9 papers). David J. Lloyd is often cited by papers focused on Pancreatic function and diabetes (13 papers), Microstructure and mechanical properties (9 papers) and Metabolism, Diabetes, and Cancer (9 papers). David J. Lloyd collaborates with scholars based in United Kingdom, United States and Canada. David J. Lloyd's co-authors include Murielle M. Véniant, Richard C. Trembath, Sue Shackleton, Glenn Sivits, Clarence Hale, Shanaka Stanislaus, Jing Xu, Michelle Chen, Steven Vonderfecht and Nicholas Gekakis and has published in prestigious journals such as The Lancet, Nature Communications and Nature Genetics.

In The Last Decade

David J. Lloyd

91 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

2008 974 citations Jing Xu, David J. Lloyd et al. profile →
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy

2000 546 citations Sue Shackleton, David J. Lloyd et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Lloyd United Kingdom	30	2.9k	690	514	513	496	96	4.7k
Yasushi Saito Japan	41	1.1k 0.4×	1.3k 1.8×	434 0.8×	828 1.6×	406 0.8×	169	5.6k
Mitsuo Kato Japan	43	4.2k 1.4×	352 0.5×	353 0.7×	598 1.2×	414 0.8×	142	6.6k
Masahiro Tsuji Japan	33	991 0.3×	366 0.5×	404 0.8×	487 0.9×	277 0.6×	198	3.5k
Hiroshi Iwata Japan	32	1.3k 0.4×	499 0.7×	324 0.6×	664 1.3×	337 0.7×	235	3.9k
Olle Nilsson Sweden	43	2.3k 0.8×	515 0.7×	131 0.3×	1.5k 3.0×	702 1.4×	201	6.0k
Sang Wan Kim South Korea	38	1.6k 0.6×	497 0.7×	890 1.7×	1.0k 2.0×	323 0.7×	187	4.6k
David P. Basile United States	37	1.7k 0.6×	402 0.6×	227 0.4×	1.1k 2.1×	316 0.6×	104	6.7k
Mark L. Johnson United States	34	2.4k 0.8×	537 0.8×	291 0.6×	381 0.7×	340 0.7×	96	4.6k
Ju‐Young Kim South Korea	32	1.1k 0.4×	798 1.2×	116 0.2×	399 0.8×	331 0.7×	170	4.2k
Yoshihiro Kikuchi Japan	33	1.3k 0.4×	380 0.6×	134 0.3×	366 0.7×	152 0.3×	201	3.9k

Countries citing papers authored by David J. Lloyd

Since Specialization

Citations

This map shows the geographic impact of David J. Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Lloyd more than expected).

Fields of papers citing papers by David J. Lloyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Lloyd. The network helps show where David J. Lloyd may publish in the future.

Co-authorship network of co-authors of David J. Lloyd

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Lloyd. A scholar is included among the top collaborators of David J. Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Lloyd. David J. Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mukherjee, Sumit, Zachary R. McCaw, David Amar, et al.. (2024). EmbedGEM: a framework to evaluate the utility of embeddings for genetic discovery. Bioinformatics Advances. 4(1). vbae135–vbae135. 1 indexed citations

Min, Xiaoshan, Junming Yie, Jinghong Wang, et al.. (2020). Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor. mAbs. 12(1). 1710047–1710047. 8 indexed citations

Killion, Elizabeth A., Michelle Chen, James R. Falsey, et al.. (2020). Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism. Nature Communications. 11(1). 110 indexed citations

Véniant, Murielle M., Glenn Sivits, Joan Helmering, et al.. (2015). Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue. Cell Metabolism. 21(5). 731–738. 172 indexed citations

Pitman, Jeffrey L., Matthew C. Wheeler, David J. Lloyd, et al.. (2014). A Gain-of-Function Mutation in Adenylate Cyclase 3 Protects Mice from Diet-Induced Obesity. PLoS ONE. 9(10). e110226–e110226. 43 indexed citations

Véniant, Murielle M., Clarence Hale, Joan Helmering, et al.. (2012). FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice. PLoS ONE. 7(7). e40164–e40164. 124 indexed citations

Gu, Wei, David J. Lloyd, Renée Komorowski, et al.. (2011). Pharmacological Targeting of Glucagon and Glucagon-Like Peptide 1 Receptors Has Different Effects on Energy State and Glucose Homeostasis in Diet-Induced Obese Mice. Journal of Pharmacology and Experimental Therapeutics. 338(1). 70–81. 28 indexed citations

Williams, Justin H. G., et al.. (2007). Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Developmental Medicine & Child Neurology. 47(8). 551–555. 31 indexed citations

Dean, John, Victoria Louise Reid, Peter D. Turnpenny, et al.. (2007). Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR. American Journal of Medical Genetics Part A. 143A(19). 2303–2311. 21 indexed citations

10.

Dean, John, Victoria Louise Reid, Susan Moore, et al.. (2007). A high frequency of the MTHFR 677C>T polymorphism in Scottish women with epilepsy: Possible role in pathogenesis. Seizure. 17(3). 269–275. 21 indexed citations

11.

Lloyd, David J., et al.. (2006). Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. Human Molecular Genetics. 15(11). 1884–1893. 105 indexed citations

12.

Thomas, Sumesh, et al.. (2005). Isolated sulphite oxidase deficiency mimics the features of hypoxic ischaemic encephalopathy. European Journal of Pediatrics. 164(11). 655–659. 29 indexed citations

13.

Richardus, Jan Hendrik, Wilco C. Graafmans, Per Bergsjø, et al.. (2003). Suboptimal care and perinatal mortality in ten European regions: methodology and evaluation of an international audit. The Journal of Maternal-Fetal & Neonatal Medicine. 14(4). 267–276. 19 indexed citations

14.

Shackleton, Sue, David J. Lloyd, Richard S. Evans, et al.. (2000). LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nature Genetics. 24(2). 153–156. 546 indexed citations breakdown →

15.

Lloyd, David J., et al.. (1996). Small bowel injury in gastroschisis: relation to fetal presentation. BJOG An International Journal of Obstetrics & Gynaecology. 103(10). 1047–1048. 3 indexed citations

16.

Turnberg, L.A., David J. Lloyd, Jane Collins, et al.. (1994). Part-time work in specialist medicine. Summary and recommendations of a report of a working party of the Royal College of Physicians.. PubMed. 28(4). 290–290. 5 indexed citations

17.

Aggett, Peter, et al.. (1991). Reduced Erythrocyte Superoxide Dismutase Activity in Low Birth Weight Infants Given Iron Supplements. Pediatric Research. 29(3). 297–301. 46 indexed citations

18.

Aggett, Peter, et al.. (1990). Routine L‐Ascorbic Acid Supplementation Does Not Alter Iron, Copper, and Zinc Balance in Low‐Birth‐Weight Infants Fed a Cows'‐Milk Formula. Journal of Pediatric Gastroenterology and Nutrition. 10(3). 351–356. 1 indexed citations

19.

Lloyd, David J., et al.. (1984). Problems of detecting mosaicism in skin. A case of trisomy 8 mosaicism illustrating the advantages of in situ tissue culture. Clinical Genetics. 25(3). 273–277. 16 indexed citations

20.

Lloyd, David J., et al.. (1970). Dislocation dynamics in the copper-tin system. Philosophical magazine. 22(180). 1147–1160. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact